At present, the inhibition of expression of PI3K, Akt and other related genes by gene knockout or small molecule drugs towards the blocking of the activation of a variety of downstream anti-effector molecules, the inhibition of angiogenesis and induction of apoptosis, has become the focus of tumor therapy research. The gene discussed is AKT1; the disease is neoplasm.